文献速递高血压血脂与心血管预防

非医师主导的多层面强化血压控制模型在老年与年轻高血压患者中的随机临床试验

Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical Trial.
PubMed 文献 · JAMA Cardiol · 2024-01-01

结果显示,老年干预组总心血管病和全因死亡风险显著降低,年轻组心血管病、卒中、心衰和心血管死亡风险亦显著降低,两组不良事件无显著差异。

要点

  • 非医师社区健康工作者主导的强化降压(<130/80 mm Hg)可安全有效降低心血管病风险。
  • ≥60岁患者干预组总心血管病HR 0.75,全因死亡HR 0.90,均显著优于常规组。
  • <60岁患者干预组总心血管病HR 0.64,卒中、心衰、心血管死亡风险亦显著降低。

核心结论

  • 在老年和年轻高血压人群中,非医师主导的多层面强化血压干预模型可有效且安全地降低心血管病和全因死亡风险。

研究设计与样本

  • CRHCP开放整群随机试验的48个月随访分析,2018至2023年在中国农村326个村庄开展。

主要发现

  • 老年组中位随访4.0(4.0-4.1)年,干预组总心血管病年发生率2.7% vs 3.5%(HR 0.75,95%CI 0.69-0.81,P<.001)。
  • 老年组全因死亡年发生率2.5% vs 2.8%(HR 0.90,95%CI 0.83-0.98,P=.01)。
  • 年轻组总心血管病HR 0.64(95%CI 0.56-0.75,P<.001),卒中HR 0.64(95%CI 0.55-0.76,P<.001)。
  • 年轻组心衰HR 0.39(95%CI 0.18-0.87,P=.02),心血管死亡HR 0.54(95%CI 0.37-0.77,P<.001)。
  • 两组年龄交互P值均>.05;两个年龄组中损伤性跌倒、症状性低血压、晕厥及肾脏结局无显著差异。

关键数值与推荐

  • 干预目标为血压<130/80 mm Hg,由非医师社区健康工作者在初级保健医生监督下启动或调整降压药物。
  • 主要复合结局包括心肌梗死、卒中、需住院心力衰竭和心血管死亡。

临床怎么用

  • 在资源有限地区,可考虑由受训非医师社区健康工作者主导、以<130/80 mm Hg为目标的强化降压管理。
  • 该模型在老年和年轻高血压患者中均显示心血管获益且未增加跌倒、低血压、晕厥等不良事件。

局限性

  • 原文未报告研究局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: The sustainable effectiveness and safety of a nonphysician community health care practitioner-led intensive blood pressure intervention on cardiovascular disease have not, to the authors' knowledge, been studied, especially in the older adult population. OBJECTIVE: To evaluate such a multifaceted model with a more stringent blood pressure treatment goal (<130/80 mm Hg) among patients aged 60 years and older with hypertension. DESIGN, SETTING, AND PARTICIPANTS: This was a 48-month follow-up study of the China Rural Hypertension Control Project (CRHCP), an open-cluster randomized clinical trial, conducted from 2018 to 2023. Participants 60 years and older and younger than 60 years with a diagnosis of hypertension from the CRHCP trial were included for analysis. Individuals were recruited from 326 villages in rural China. INTERVENTIONS: The well-trained, nonphysician, community health care practitioner implemented a multifaceted intervention program (eg, initiation or titration of antihypertensive medications) to achieve a blood pressure level of less than 130/80 mm Hg, supervised by primary care physicians. MAIN OUTCOMES AND MEASURES: Cardiovascular disease (a composite of myocardial infarction, stroke, heart failure requiring hospitalization, and cardiovascular disease death). RESULTS: A total of 22 386 individuals 60 years and older with hypertension and 11 609 individuals younger than 60 years with hypertension were included in the analysis. The mean (SD) age of the participants was 63.0 (9.0) years and included 20 825 females (61.3%). Among the older individuals with hypertension, a total of 11 289 patients were randomly assigned to the intervention group and 11 097 to the usual-care group. During a median (IQR) of 4.0 (4.0-4.1) years, there was a significantly lower rate of total cardiovascular disease (1133 [2.7%] vs 1433 [3.5%] per year; hazard ratio [HR], 0.75; 95% CI, 0.69-0.81; P < .001) and all-cause mortality (1111 [2.5%] vs 1210 [2.8%] per year; HR, 0.90; 95% CI, 0.83-0.98; P = .01) in the intervention group than in the usual-care group. For patients younger than 60 years, the risk reductions were also significant for total cardiovascular disease (HR, 0.64; 95% CI, 0.56-0.75; P < .001), stroke (HR, 0.64; 95% CI, 0.55-0.76; P < .001), heart failure (HR, 0.39; 95% CI, 0.18-0.87; P = .02), and cardiovascular death (HR, 0.54; 95% CI, 0.37-0.77; P < .001), with all interaction P values for age groups greater than .05. In both age categories, the incidences of injurious falls, symptomatic hypotension, syncope, and the results for kidney outcomes did not differ significantly between groups. CONCLUSIONS AND RELEVANCE: In both the aging and younger general population with hypertension, the nonphysician health care practitioner-led, multifaceted, intensive blood pressure intervention model could effectively and safely reduce the risk of cardiovascular disease and all-cause death. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03527719.

来源:JAMA Cardiol,查看原文。版权归原作者所有。

引用

  1. Guo X, Ouyang N, Sun G, et al. Multifaceted Intensive Blood Pressure Control Model in Older and Younger Individuals With Hypertension: A Randomized Clinical Trial. JAMA Cardiol. 2024. PMID: 38888905. doi:10.1001/jamacardio.2024.1449

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。